Resources

The n-of-1 that counts

Elvira’s story shows us the amazing potential for n-of-1 trials and SCEDs to help each of us figure out exactly what’s going on in our own lives. They can help us use our own PGHD to determine what actually influences our own health each and every day, regardless of how those same triggers harm—or may even help—others.

Eric J. Daza

Measuring health-related quality of life with multimodal data: Viewpoint

Evidation contributed to a summary of how multimodal technologies capable of measuring several modalities simultaneously provide value to stakeholders.

Ieuan Clay, Francesca Cormack, Szymon Fedor, Luca Foschini, Giovanni Gentile, Chris van Hoof, Priya Kumar, Florian Lipsmeier, Akane Sano, Benjamin Smarr, Benjamin Vandendriessche, Valeria De Luca

Evidation partners with other industry leaders to launch resources to drive inclusion in digital health measurement

Evidation and other members of the Digital Health Measurement Collaborative Community (DATAcc) announced a new set of open-access resources to guide inclusivity in digital health measurement products from development to deployment.

Next generation patient engagement & enriched insights

Evidation has written a white paper that takes a closer look at the challenges of PGHD, its value to clinical decision makers, and how to contextualize it to optimize its value.

COPD — Determine high-impact clinical markers with person-generated health data (PGHD)

Combining activity and behavioral-related data can predict exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients

Estimating the burden of influenza-like illness on daily activity at the population scale using commercial wearable sensors

Evidation research reveals that most of the burden of influenza-like illness is invisible to health care and public health reporting systems.

Aziz Mezlini, Allison Shapiro, Eric J. Daza, Eamon Caddigan, Ernesto Ramirez, Tim Althoff, Luca Foschini

How do we make patient centricity a reality?

For years, the subject of fostering direct connections with patients has been highlighted by notable figures across the healthcare and life sciences industries as a key feature to be explored in future strategies.

Rheumatoid Arthritis — The pandemic’s impact on Rx adherence & access to care

Non-adherence to medication & unwillingness to visit health facilities soar due to COVID-19.

Asthma — PGHD delivers a roadmap to optimal treatment

Person-generated health data (PGHD) allows users to identify and segment patients based on real world behaviors and disease impact.

Creating competitive advantage: Privacy and security by design in mHealth and digital health products

Evidation's Head of Privacy looks at the increased need for cybersecurity and privacy protection amidst the boom in digital health advancements.

Alea Garbagnati, Esq. and Lauren Wu, Esq.